Akèy › Glomeruloskleroz fokal segmantè › North Carolina
Etid klinik pou Glomeruloskleroz fokal segmantè nan North Carolina
9 etid pou Glomeruloskleroz fokal segmantè ap chèche patisipan nan sit nan North Carolina.
Vil nan North Carolina
Tèks ofisyèl etid la (Anglè)
A Study of Praliciguat in Participants With Focal Segmental Glomerulosclerosis (FSGS)
- Investigator Site #16, New Bern
Ap rekriteFaz 2
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT07268638A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)
- Duke University Medical Center, Durham
- Carolina Kidney Associates, Greensboro
- Cardinal Clinical Research, LLC - Shelby, Shelby
Ap rekriteFaz 3
Laj 12 ak plis · Tout sèks · Mizajou Sep 30, 2026 · NCT07220083A Study to Evaluate the Efficacy and Safety of Frexalimab, Brivekimig, or Rilzabrutinib in Participants Aged 16 to 75 Years With Primary Focal Segmental Glomerulosclerosis or Minimal Change Disease
- UNC Kidney Center- Site Number : 8400021, Chapel Hill
Ap rekriteFaz 2
Laj 16 a 75 · Tout sèks · Mizajou Sep 23, 2026 · NCT06500702Post Approval Study for Treatment of Drug-resistant Adult and Pediatric Primary FSGS Using the LIPOSORBER® LA-15 System
- University of North Carolina, Chapel Hill
Ap rekrite
Jiska laj 75 · Tout sèks · Mizajou Aug 28, 2026 · NCT04065438Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- University of North Carolina, Chapel Hill
Ap rekrite
Jiska laj 21 · Tout sèks · Mizajou Aug 28, 2026 · NCT02235857Nephrotic Syndrome Study Network
- University of North Carolina at Chapel Hill, Chapel Hill
- Atrium Health Levine Children's Hospital, Charlotte
Ap rekriteEtid obsèvasyon
Jiska laj 80 · Tout sèks · Mizajou Jun 10, 2026 · NCT01209000NEPTUNE Match Study
- University of North Carolina Chapel Hill, Chapel Hill
Ap rekrite
Laj 1 a 80 · Tout sèks · Mizajou Jun 10, 2026 · NCT04571658Study of Sparsentan Treatment in Pediatrics With Proteinuric Glomerular Diseases
- University of North Carolina at Chapel Hill, Chapel Hill
- Duke Molecular Physiology Institute, Durham
Ap rekriteFaz 2
Laj 1 a 17 · Tout sèks · Mizajou May 12, 2026 · NCT05003986A Study of the Efficacy and Safety of DMX-200 in Patients With FSGS Who Are Receiving an ARB
- University of North Carolina, Chapel Hill
- Atrium Health, Charlotte
Ap rekriteFaz 3
Laj 12 a 80 · Tout sèks · Mizajou Feb 3, 2026 · NCT05183646Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.